GL Pharm Tech Corp. (KOSDAQ:204840)

GL Pharm Tech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,258	4,136	4,639	6,189	9,490
Cash & Short-Term Investments	4,258	4,136	4,639	6,189	9,490
Cash Growth	2.95%	-10.86%	-25.03%	-34.78%	1341.31%
Accounts Receivable	5,804	5,618	5,514	3,480	3,522
Other Receivables	214.16	173.99	156.25	180.71	113.61
Receivables	6,018	5,792	5,671	3,660	3,636
Inventory	8,550	6,640	5,508	3,387	2,742
Prepaid Expenses	5.39	2.14	-	0.2	0.4
Other Current Assets	182.28	49.21	372.14	32.77	101.56
Total Current Assets	19,014	16,619	16,190	13,270	15,970
Property, Plant & Equipment	18,127	18,864	19,850	15,465	15,636
Long-Term Investments	3,012	2,992	3,020	1,024	525.86
Goodwill	-	-	-	-	278.13
Other Intangible Assets	780.33	819.28	1,043	1,253	1,457
Long-Term Deferred Charges	899.65	208.33	435.8	663.27	890.74
Other Long-Term Assets	573.19	189.61	144.75	121.3	100.65
Total Assets	42,440	39,868	40,854	31,895	34,945
Accounts Payable	1,970	2,564	3,104	623.4	895.04
Accrued Expenses	700.45	1,017	1,707	645	651.27
Short-Term Debt	2,983	4,380	2,030	1,980	3,929
Current Portion of Long-Term Debt	5,697	2,000	4,350	249.96	249.96
Current Portion of Leases	92.46	77.92	71.68	88.82	71.15
Current Unearned Revenue	150	335	50	-	225
Other Current Liabilities	2,320	1,945	1,790	1,278	1,640
Total Current Liabilities	13,914	12,319	13,104	4,865	7,662
Long-Term Debt	5,650	11,247	7,400	5,450	8,652
Long-Term Leases	227.49	79.94	57.92	109.94	114.91
Long-Term Unearned Revenue	893.8	943.07	1,313	1,032	1,031
Long-Term Deferred Tax Liabilities	2,010	2,005	2,200	2,243	2,818
Other Long-Term Liabilities	-0	-0	0	0	0
Total Liabilities	22,772	27,586	24,764	14,415	20,630
Common Stock	7,697	6,235	6,210	6,185	4,721
Additional Paid-In Capital	34,067	25,615	25,558	25,795	19,982
Retained Earnings	-21,588	-19,251	-15,502	-15,313	-11,193
Treasury Stock	-0.11	-0.11	-0.11	-0.11	-0.11
Comprehensive Income & Other	-507.42	-317.23	-175.7	182.01	303.02
Total Common Equity	19,668	12,282	16,090	16,849	13,813
Minority Interest	-	-	-	630.18	-
Shareholders' Equity	19,668	12,282	16,090	17,480	14,315
Total Liabilities & Equity	42,440	39,868	40,854	31,895	34,945
Total Debt	14,650	17,785	13,910	7,879	13,017
Net Cash (Debt)	-10,393	-13,650	-9,270	-1,690	-3,527
Net Cash Per Share	-137.83	-218.48	-149.46	-33.23	-78.39
Filing Date Shares Outstanding	81.51	62.35	62.1	61.85	47.21
Total Common Shares Outstanding	81.51	62.35	62.1	61.85	47.21
Working Capital	5,100	4,301	3,086	8,404	8,308
Book Value Per Share	241.30	196.98	259.09	272.40	292.58
Tangible Book Value	18,888	11,463	15,047	15,596	12,078
Tangible Book Value Per Share	231.72	183.84	242.29	252.15	255.83
Land	10,266	10,266	10,266	9,491	9,491
Buildings	7,530	7,530	7,530	4,417	4,567
Machinery	8,727	8,674	8,180	8,130	7,703
Construction In Progress	15.85	-	200	254	109.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.